No Detail Found!

Regulation of glucagon, somatostatin and glp-1 by insulin and forskolin in rats

Author(s)
Farooq Ahmad Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
Abdul Khaliq Naveed Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
Abstract
Glucagon had stimulatory effect on insulin secretion and insulin inhibits glucagon release. The possible mechanism of insulin effect on proglucagon gene transcription under physiological conditions has to be established. Conflicting reports exist regarding signal pathway involved in the regulation of islet and intestinal glucagon producing cells, therefore, present study was designed to determine the in-vivo effect of insulin and forskolin on glucagon. Design : Prospective and experimental study. Place and Duration of Study: The study was conducted in the Department of Chemical Pathology & Endocrinology, Armed Forces Institute of Pathology, Rawalpindi. Laboratory facilities of the Department of Metabolic Medicine, Hammersmith Hospital, London were used for specialized procedures. The study was completed in one year. Subjects and Methods: An in-vivo study was conducted by producing hyperinsulinaemic, isoglycaemic clamp. Forskolin, which is a direct activator of adenylate cyclase system, was infused to diabetic rats to establish the second messenger involved in the regulation of islets cell function and intestinal glucagon gene transcription. Results: Insulin decreased glucagon secretion and its mRNA in rats infused with insulin as compared to controls. Plasma levels of glucagon was more in diabetic as compared to non diabetic control rats. It is interpreted that glucagon mRNA in diabetic controlled rats will also be more as compared to normal controlled rats. GLP-1 level in diabetic controls was more as compared to non diabetic controls indicating loss of inhibitory effect on intestinal glucagon by insulin in diabetics. Insulin infusion significantly decreased GLP-1 levels in diabetic rats. Forskolin did not affect the glucagon secretion or its mRNA in pancreas but it increased GLP-1 levels in plasma of rats. Somatostatin levels decreased by insulin and a significant hypersomatostatinemia was observed in diabetic controls as compared to non diabetic control rats. Forskolin increased somatostatin and insulin secretions. Concentrations of insulin were significantly high (about 10 times) as compared to controls in rats infused with insulin. Conclusion: It is concluded that insulin normalizes hyperglucagonemia in diabetics by exerting its effects at gene transcription level. Insulin also negatively regulates intestinal proglucagon gene. Somatostatin is negatively regelated by insulin. The cAMP dependent pathway may be involved in the regulation of glucagon gene in intestine. Pancreatic B and D cells are stimulated by cAMP dependent pathway. The increased insulin, somatostatin and GLP-1 in response to forskolin may have masked the effect of forskolin on A cells, due to which no effect on glucagon secretion and synthesis was observed. .
Publication Details
Page(s) 4-11
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 12, Issue: 1, Year: 2002

Request the full text from PASTIC

Keywords
Insulin, glucagon, Somatostatin, Diabetes mellites
References
Philippe J .1988 .Proglucagognene expressionand posttranslatiopnraolcessingin a hamsteirsletcelline. Endocrinology, 123 : 1861-7.
.1992 .. JChin invest, 89 : 432-6.
Elahi DM,Mullac JD,Blix AH .1982 .. EngiJMed, 306 : 1196-202.
.1992 .CyclicAMP prevents theglucocorticomidesdiate dinhibitionofinsulingene expressionin roden tisletcellJ. Ctin invest, 130 : 2890-6.
Skolund G .2000 .proteinkinase a independentactivatioonf insulin I gene cAMP responsivelementsD. iabetes, 49(7) : 1156-64.
. .pancreaticpolypeptidesecretione:ffect of glucagoni,nsulinandarginine. Diabetes V3TS', 28 : 35-40.
.1983 .Opposingactionsofglucagonand insulinon splanchnicD cellfunction. JCiininvest, 71 : 721-5.
.1983 .-vivo insulinsensitivitiyn theratdeterminebdy euglycemic clampA. , : E1-7.
O'ShaughnessyDJ. SomatostaiInn:: Bloom' SR,Long GR . .Radioimmunoassayof gut regulatory peptidesP.hiladelphia. WBSaundersV&2., : .
.1987 .Single-stepmethodof RNA isolationby acid guanidium thiocyanatpehenol chlorodoremxtractioAnn. a!Biochem, 162 : 156-9.
. .. , : .
Unger RH,McCall MS .1962 .MadisonLL. Measuremenotf endogenousglucagonin plasmaand theinfluenceof bloodglucoseconcentratiuopnon its secretionJC. iininvest, 41 : 682-9.
.1987 .Relationshoipfglucagon suppressionby insulin and somatostattino ambient glucoseconcentratioJnC. hininvest, 79 : 20-4.
.1997 .Modulatioonf gliquidone actionby forskoliinn thepancriasof normaland GK ratsA. , 273(1) : E52-8.
.1995 .Somatostatcinoordinaterleygulatgelucagongene expressionandexocytosiisn HIT-T15 cellsJ. Ciin invest, 96 : 2496-502.
.1990 .Suppressionof synthesisand releasoef glucagonby GLP-1 withoutaffecton mRNA leve lin isolaterdatisletsB. iochem Biophys Bes Common, 167 : 431-7.
Fehmann HC,HabnerJF. Insulinotropihcormone HC .1992 .stimulatioonf proinsulin gene expressionand proinsulinbiosynthesis in insulinomaB TC-1 cellsE. , 130(7) : 159-66.
.1995 .Identificatioonf a cAMP responsivelement 49. EndocrRev, 16 : 390-410.
Me IntoshC .1985 .. RIN-5F cellsJ.Bio! Chem, 260 : 13585-9.
. .Comparisonof GLP-1 and GIP on releaseof somatostatilnikeimmunoreactiviatynd insulinfrom theisolaterdatpancreasZ. Gastroenterol1990, 28 : 280-4.
.1994 .. ASEBJ, 8 : 20-7.
Kaneko T,Nagai M .1999 .SharpGW, HashizumuK. cAMP enhances insulinsecretiobny an actionon theATP-sensitive potassiumchannelindependentpathwayof glucose signallingin ratpancreatiicslets. Diabetes, 48 : 1006-12.
0

Citations

0

Downloads

41

Views